Related Experiment Video
Updated: Aug 10, 2026

DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
Published on: July 15, 2011
An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular
1Foundation for Medical Research, Worli, Bombay, India.
Abstract:
The delipidified cell components of Mycobacterium leprae (DCC) obtained as an insoluble material was presented as an antigen by the macrophages of lepromatous leprosy patients. This resulted in in vitro lymphocyte proliferation and production of lymphokines, like IL-2 and IFN-gamma. This DCC induced culture supernatant was capable of activating patient macrophages through changes induced in the membrane, as monitored by same specific markers, before and after exposure to the supernatant. The activated macrophages could recognise M. leprae as an antigen to initiate cell mediated immunity and also recognise the bacilli as a pathogen to produce superoxide leading to the killing of phagocytosed M. leprae. Based on these observations, it is indicated that DCC could be a potent immunomodulatory restoring in the phagocytes of leprosy patients to kill M. leprae like normal resistant individuals.
Insights
Delipidified cell components of Mycobacterium leprae (DCC) activate macrophages in leprosy patients. This restores their ability to recognize and kill M. leprae, suggesting DCC as a potential immunomodulatory treatment.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Leprosy, caused by Mycobacterium leprae, involves complex immune responses.
- Macrophages play a crucial role in cell-mediated immunity against M. leprae.
- Defective macrophage function is observed in lepromatous leprosy.
Purpose of the Study:
- To investigate the immunomodulatory potential of delipidified cell components of Mycobacterium leprae (DCC).
- To assess DCC's ability to restore macrophage function in lepromatous leprosy patients.
- To explore DCC as a therapeutic strategy for enhancing anti-mycobacterial immunity.
Main Methods:
- DCC was prepared from M. leprae.
- Macrophages from lepromatous leprosy patients were exposed to DCC.
- In vitro lymphocyte proliferation and lymphokine production (IL-2, IFN-gamma) were measured.
- Macrophage activation was monitored using specific membrane markers.
- Superoxide production by activated macrophages was assessed.
Main Results:
- DCC presented as an antigen by macrophages induced lymphocyte proliferation and lymphokine production.
- DCC-induced supernatant activated patient macrophages, altering membrane markers.
- Activated macrophages recognized M. leprae and produced superoxide.
- Phagocytosed M. leprae were killed by activated macrophages.
Conclusions:
- DCC acts as a potent immunomodulator in leprosy patients.
- DCC restores phagocyte function, enabling M. leprae killing.
- DCC holds promise for restoring cell-mediated immunity in lepromatous leprosy.
More Related Videos
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antiprotozoal Agents

